FOLFOXIRI: Clinical Trials

17 trials of FOLFOXIRI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 6 unknown, 1 active not recruiting, 1 recruiting. 17 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 217Completed 7, Unknown 6, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1

Follow FOLFOXIRI: new trials by email Literature Review of FOLFOXIRI trials Research Report on FOLFOXIRI

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
FOLFOXIRI, XELOX - Colon Cancer
Phase 2RecruitingWest China Hospital602024-03-252024-12-12
Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III
FOLFOXIRI, CAPOX - Colorectal Neoplasms Malignant, Minimal Residual Disease
Phase 2Active not recruitingFundación para la Investigación del Hospital Clínico de Valencia452022-01-012026-09-15
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
Cetuximab, Bevacizumab, FOLFOXIRI - Liver Metastasis Colon Cancer
Phase 2UnknownFudan University1602021-04-172021-04-06
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
FOLFOXIRI, FOLFOX regimen, XELOX - Rectal Cancer
Phase 2CompletedStanford University382020-05-212025-02-25
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
FOLFOXIRI - Colorectal Neoplasms, Drug Therapy
Phase 2UnknownChina Medical University, China302018-05-012021-04-19
Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer
FOLFOXIRI - Colonic Neoplasms, Drug Therapy
Phase 2UnknownChina Medical University, China302018-04-012021-04-19
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
FOLFOXIRI, Short-Course Radiation Therapy(5Gy*5), XELOX - Rectal Neoplasms, Drug Therapy
Phase 2UnknownChina Medical University, China302018-04-012021-04-14
FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer
FOLFOXIRI - Rectal Cancer
Phase 2WithdrawnGuangxi Medical University2017-08-112019-08-08
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
FOLFOXIRI, FOLFOX, FOLFIRI - Metastatic Colorectal Cancer
Phase 2TerminatedCentre Hospitalier Universitaire de Besancon542017-08-042025-02-05
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
FOLFOXIRI - Rectal Cancer
Phase 2UnknownRenJi Hospital1002016-11-012018-01-03
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
FOLFOXIRI - Locally Advanced Rectal Cancer
Phase 2CompletedAiping Zhou502016-02-062021-02-01
FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type
FOLFOXIRI + Bevacizumab, FOLFOXIRI - Metastatic Colorectal Cancer
Phase 2CompletedSun Yat-sen University1382015-01-012026-05-22
Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer
FOLFOXIRI - Rectal Cancer
Phase 2CompletedSun Yat-sen University1002014-08-152021-04-14
FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
FOLFOXIRI, FOLFOX - Metastatic Colorectal Cancer
Phase 2UnknownSun Yat-sen University1622014-04-012014-05-07
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer
FOLFOXIRI + Cetuximab, FOLFOXIRI - Metastatic Colorectal Cancer
Phase 2CompletedSun Yat-sen University1012014-02-012020-03-31
FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer
FOLFOXIRI - Pancreatic Carcinoma Stage III
Phase 2CompletedAzienda Ospedaliero, Universitaria Pisana502012-12-012015-01-30
FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)
FOLFOXIRI + Panitumumab, FOLFOXIRI - Metastatic Colorectal Cancer
Phase 2CompletedAIO-Studien-gGmbH932011-04-012023-06-15

Conditions studied

Colorectal Neoplasms (6)  ·  Rectal Neoplasms (6)  ·  Colonic Neoplasms (3)  ·  Neoplasm, Residual (1)  ·  Neoplastic Cells, Circulating (1)  ·  Pancreatic Neoplasms (1)

Sponsors

Sun Yat-sen University (4)  ·  China Medical University, China (3)  ·  AIO-Studien-gGmbH (1)  ·  Aiping Zhou (1)  ·  Azienda Ospedaliero, Universitaria Pisana (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Fudan University (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Guangxi Medical University (1)  ·  RenJi Hospital (1)  ·  Stanford University (1)  ·  West China Hospital (1)

Countries

China (12)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Yanhong Deng, M.D. (3)  ·  Jingdong Zhang (2)  ·  Aiping Zhou, Doctor (1)  ·  Erqi L Pollom (1)  ·  Ming Ye, Master (1)  ·  Wen Zhang (1)  ·  Yuzhou Qin (1)

Results publications

PMID 31609637, PMID 35834598, PMID 37370032, PMID 38902952, PMID 39753246, PMID 42743885

NIH funding

2009 (1)